Quantcast
Home > Quotes > ZLAB

Zai Lab Limited American Depositary Shares Quote & Summary Data

ZLAB 
$25.28
*  
0.35
1.37%
Get ZLAB Alerts
*Delayed - data as of Dec. 13, 2017  -  Find a broker to begin trading ZLAB now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Intraday Chart

News for ZLAB

Shares Traded

Trading Range

The current last sale of $25.28 is 6.22% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 26 $ 35.74
 Low: $ 25.26 $ 23.80

Company Description (as filed with the SEC)

We are an innovative biopharmaceutical company based in Shanghai focusing on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including in the fields of oncology, autoimmune and infectious diseases. We believe there exists a significant opportunity to build an organization that not only addresses such unmet needs but leverages underutilized resources in China to foster innovation. As part of that effort, we have assembled a management team with global experience and an extensive track record in navigating the regulatory process to develop and commercialize innovative drugs in China. Our mission is to leverage our expertise and insight to address the expanding needs of Chinese patients in order to transform their lives and eventually utilize our China-based competencies to impact human health worldwide.  ... More ...  

Risk Grade

Where does ZLAB fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Analyst Info